AVN-101
- Generic Name
- AVN-101
A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
Phase 3
- Conditions
- Anxiety Disorder Generalized
- Interventions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- ChemRar Research and Development Institute, LLC
- Target Recruit Count
- 200
- Registration Number
- NCT04598867
А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- ChemRar Research and Development Institute, LLC
- Target Recruit Count
- 129
- Registration Number
- NCT04524975
- Locations
- 🇷🇺
St. Petersburg "Psychoneurological dispensary #5", Saint Petersburg, Russian Federation
🇷🇺"Research Center for Mental Health" Scientific Institution, Moscow, Russian Federation
🇷🇺Clinical Center LLC "Doctor SAN", Saint Petersburg, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath